Table 1.
Treatment | Cell-cycle distribution | |||
---|---|---|---|---|
Sub-G1 (%) | G0/G1 (%) | S (%) | G2/M (%) | |
Control | 1.9 | 69.1 | 13.9 | 14.2 |
JP-1 150 μg/mL | 2.8 | 67.9 | 14.3 | 13.9 |
JP-1 300 μg/mL | 15.6 | 56.4 | 14.0 | 12.4 |
JP-1 450 μg/mL | 63.8 | 26.1 | 6.1 | 3.7 |
Treatment | Cell-cycle distribution | |||
---|---|---|---|---|
Sub-G1 (%) | G0/G1 (%) | S (%) | G2/M (%) | |
Control | 1.9 | 69.1 | 13.9 | 14.2 |
JP-1 150 μg/mL | 2.8 | 67.9 | 14.3 | 13.9 |
JP-1 300 μg/mL | 15.6 | 56.4 | 14.0 | 12.4 |
JP-1 450 μg/mL | 63.8 | 26.1 | 6.1 | 3.7 |